TGFB1 and neoplasm: Furthermore, we also obtained the upregulation of tumor stem cell markers (CD44, CD133, and OCT4) in HepG2, HepB3, and LM3 cells with the TGF-β1 treatment at both RNA and protein levels (Figures 1D, E).